Peer-influenced content. Sources you trust. No registration required. This is HCN.

The New England Journal of MedicineLuspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Can transfusion independence for multiple weeks be possible in patients with myelodysplastic syndromes? Read on to discover promising information you can share with your patients about reducing the severity of their anemia.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form